Cheil Bio Co

Cheil Bio Co ROCE

Delisted·Feb 25, 2026

The Return on Capital Employed (ROCE) of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is -6.49 %. In the previous year, Return on Capital Employed (ROCE) was -4.75 % — a change of 36.63% (lower).

ROCE

-6.49 %

YoY

36.63%

Last updated:

In 2023, Cheil Bio Co's return on capital employed (ROCE) was -6.49 %, a 36.63% increase from the -4.75 % ROCE in the previous year.

The Cheil Bio Co ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2016
2.28 KRW
Jan 1, 2017
3.65 KRW
Jan 1, 2018
4.71 KRW
Jan 1, 2019
1.58 KRW
Jan 1, 2020
-1.28 KRW
Jan 1, 2021
-4.62 KRW
Jan 1, 2022
-4.75 KRW
Jan 1, 2023
-6.49 KRW
The Cheil Bio Co ROCE history
YEARROCEYoY
-6.49 %+36.63%
-4.75 %+2.78%
-4.62 %+261.76%
-1.28 %-180.71%
1.58 %-66.37%
4.71 %+29.10%
3.65 %+60.30%
2.28 %-26.98%
3.12 %-47.38%
5.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Cheil Bio Co's Return on Capital Employed (ROCE)

Cheil Bio Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Cheil Bio Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Cheil Bio Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Cheil Bio Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Cheil Bio Co stock

Return on Capital Employed (ROCE) of Cheil Bio Co is -6.49 % in 2023.

Return on Capital Employed (ROCE) of Cheil Bio Co changed from -4.75 % to -6.49 %, representing a 36.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Cheil Bio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Cheil Bio Co

All Key Metrics — Cheil Bio Co